Inhibition of key DNA double strand break repair protein kinases enhances radiosensitivity of head and neck cancer cells to X-ray and proton irradiation

被引:1
作者
Fabbrizi, Maria Rita [1 ]
Doggett, Thomas J. [2 ]
Hughes, Jonathan R. [1 ]
Melia, Emma [1 ]
Dufficy, Elizabeth R. [1 ]
Hill, Rhianna M. [2 ]
Goula, Amalia [1 ]
Phoenix, Ben [3 ]
Parsons, Jason L. [1 ,3 ]
机构
[1] Univ Birmingham, Inst Canc & Genom Sci, Birmingham, England
[2] Univ Liverpool, Dept Mol & Clin Canc Med, Liverpool, England
[3] Univ Birmingham, Sch Phys & Astron, Edgbaston, England
关键词
UP-REGULATION; TUMOR-CELLS; RADIATION; ATR; PATHWAY;
D O I
10.1038/s41420-024-02059-3
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Ionising radiation (IR) is widely used in cancer treatment, including for head and neck squamous cell carcinoma (HNSCC), where it induces significant DNA damage leading ultimately to tumour cell death. Among these lesions, DNA double strand breaks (DSBs) are the most threatening lesion to cell survival. The two main repair mechanisms that detect and repair DSBs are non-homologous end joining (NHEJ) and homologous recombination (HR). Among these pathways, the protein kinases ataxia telangiectasia mutated (ATM), ataxia telangiectasia and Rad3-related (ATR) and the DNA dependent protein kinase catalytic subunit (DNA-Pkcs) play key roles in the sensing of the DSB and subsequent coordination of the downstream repair events. Consequently, targeting these kinases with potent and specific inhibitors is considered an approach to enhance the radiosensitivity of tumour cells. Here, we have investigated the impact of inhibition of ATM, ATR and DNA-Pkcs on the survival and growth of six radioresistant HPV-negative HNSCC cell lines in combination with either X-ray irradiation or proton beam therapy, and confirmed the mechanistic pathway leading to cell radiosensitisation. Using inhibitors targeting ATM (AZD1390), ATR (AZD6738) and DNA-Pkcs (AZD7648), we observed that this led to significantly decreased clonogenic survival of HNSCC cell lines following both X-ray and proton irradiation. Radiosensitisation of HNSCC cells grown as 3D spheroids was also observed, particularly following ATM and DNA-Pkcs inhibition. We confirmed that the inhibitors in combination with X-rays and protons led to DSB persistence, and increased micronuclei formation. Cumulatively, our data suggest that targeting DSB repair, particularly via ATM and DNA-Pkcs inhibition, can exacerbate the impact of ionising radiation in sensitising HNSCC cell models.
引用
收藏
页数:10
相关论文
共 37 条
  • [11] The brain-penetrant clinical ATM inhibitor AZD1390 radiosensitizes and improves survival of preclinical brain tumor models
    Durant, Stephen T.
    Zheng, Li
    Wang, Yingchun
    Chen, Kan
    Zhang, Lingli
    Zhang, Tianwei
    Yang, Zhenfan
    Riches, Lucy
    Trinidad, Antonio G.
    Fok, Jacqueline H. L.
    Hunt, Tom
    Pike, Kurt G.
    Wilson, Joanne
    Smith, Aaron
    Colclough, Nicola
    Reddy, Venkatesh Pilla
    Sykes, Andrew
    Janefeldt, Annika
    Johnstrom, Peter
    Varnas, Katarina
    Takano, Akihiro
    Ling, Stephanie
    Orme, Jonathan
    Stott, Jonathan
    Roberts, Caroline
    Barrett, Ian
    Jones, Gemma
    Roudier, Martine
    Pierce, Andrew
    Allen, Jasmine
    Kahn, Jenna
    Sule, Amrita
    Karlin, Jeremy
    Cronin, Anna
    Chapman, Melissa
    Valerie, Kristoffer
    Illingworth, Ruth
    Pass, Martin
    [J]. SCIENCE ADVANCES, 2018, 4 (06):
  • [12] Cytokinesis-block micronucleus cytome assay
    Fenech, Michael
    [J]. NATURE PROTOCOLS, 2007, 2 (05) : 1084 - 1104
  • [13] Cancer statistics for the year 2020: An overview
    Ferlay, Jacques
    Colombet, Murielle
    Soerjomataram, Isabelle
    Parkin, Donald M.
    Pineros, Marion
    Znaor, Ariana
    Bray, Freddie
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2021, 149 (04) : 778 - 789
  • [14] AZD7648 is a potent and selective DNA-PK inhibitor that enhances radiation, chemotherapy and olaparib activity
    Fok, Jacqueline H. L.
    Ramos-Montoya, Antonio
    Vazquez-Chantada, Mercedes
    Wijnhoven, Paul W. G.
    Follia, Valeria
    James, Neil
    Farrington, Paul M.
    Karmokar, Ankur
    Willis, Sophie E.
    Cairns, Jonathan
    Nikkila, Jenni
    Beattie, David
    Lamont, Gillian M.
    Finlay, M. Raymond, V
    Wilson, Joanne
    Smith, Aaron
    O'Connor, Lenka Oplustil
    Ling, Stephanie
    Fawell, Stephen E.
    O'Connor, Mark J.
    Hollingsworth, Simon J.
    Dean, Emma
    Goldberg, Frederick W.
    Davies, Barry R.
    Cadogan, Elaine B.
    [J]. NATURE COMMUNICATIONS, 2019, 10 (1)
  • [15] The Major DNA Repair Pathway after Both Proton and Carbon-Ion Radiation is NHEJ, but the HR Pathway is More Relevant in Carbon Ions
    Gerelchuluun, Ariungerel
    Manabe, Eri
    Ishikawa, Takaaki
    Sun, Lue
    Itoh, Kazuya
    Sakae, Takeji
    Suzuki, Kenshi
    Hirayama, Ryoichi
    Asaithamby, Aroumougame
    Chen, David J.
    Tsuboi, Koji
    [J]. RADIATION RESEARCH, 2015, 183 (03) : 345 - 356
  • [16] Novel DNA targeted therapies for head and neck cancers: clinical potential and biomarkers
    Glorieux, Mary
    Dok, Ruveyda
    Nuyts, Sandra
    [J]. ONCOTARGET, 2017, 8 (46) : 81662 - 81678
  • [17] Combined ATR and DNA-PK Inhibition Radiosensitizes Tumor Cells Independently of Their p53 Status
    Hafsi, Hind
    Dillon, Magnus T.
    Barker, Holly E.
    Kyula, Joan N.
    Schick, Ulrike
    Paget, James T.
    Smith, Henry G.
    Pedersen, Malin
    McLaughlin, Martin
    Harrington, Kevin J.
    [J]. FRONTIERS IN ONCOLOGY, 2018, 8
  • [18] The DNA-damage response in human biology and disease
    Jackson, Stephen P.
    Bartek, Jiri
    [J]. NATURE, 2009, 461 (7267) : 1071 - 1078
  • [19] Proton Therapy for Head and Neck Cancer
    Kim, Joseph K.
    Leeman, Jonathan E.
    Riaz, Nadeem
    McBride, Sean
    Tsai, Chiaojung Jillian
    Lee, Nancy Y.
    [J]. CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2018, 19 (06)
  • [20] Lower ataxia telangiectasia mutated (ATM) mRNA expression is correlated with poor outcome of laryngeal and pharyngeal cancer patients
    Lee, K. -W.
    Tsai, Y. -S.
    Chiang, F. -Y.
    Huang, J. -L.
    Ho, K. -Y.
    Yang, Y. -H.
    Kuo, W. -R.
    Chen, M. -K.
    Lin, C. -S.
    [J]. ANNALS OF ONCOLOGY, 2011, 22 (05) : 1088 - 1093